X-18564526-GATATATATATATAT-GATATATATATAT
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001323289.2(CDKL5):c.145+27_145+28delAT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0538 in 556,775 control chromosomes in the GnomAD database, including 12 homozygotes. There are 400 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 5 hom., 203 hem., cov: 19)
Exomes 𝑓: 0.063 ( 7 hom. 197 hem. )
Consequence
CDKL5
NM_001323289.2 intron
NM_001323289.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.405
Publications
0 publications found
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant X-18564526-GAT-G is Benign according to our data. Variant chrX-18564526-GAT-G is described in ClinVar as Benign. ClinVar VariationId is 239511.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0105 (977/93077) while in subpopulation NFE AF = 0.015 (696/46299). AF 95% confidence interval is 0.0141. There are 5 homozygotes in GnomAd4. There are 203 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check.
BS2
High AC in GnomAd4 at 977 XL,AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKL5 | NM_001323289.2 | c.145+27_145+28delAT | intron_variant | Intron 4 of 17 | ENST00000623535.2 | NP_001310218.1 | ||
| CDKL5 | NM_001037343.2 | c.145+27_145+28delAT | intron_variant | Intron 5 of 21 | NP_001032420.1 | |||
| CDKL5 | NM_003159.3 | c.145+27_145+28delAT | intron_variant | Intron 4 of 20 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0105 AC: 977AN: 93107Hom.: 5 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
977
AN:
93107
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0643 AC: 4674AN: 72668 AF XY: 0.000648 show subpopulations
GnomAD2 exomes
AF:
AC:
4674
AN:
72668
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0625 AC: 29001AN: 463698Hom.: 7 AF XY: 0.00206 AC XY: 197AN XY: 95852 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
29001
AN:
463698
Hom.:
AF XY:
AC XY:
197
AN XY:
95852
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
680
AN:
12507
American (AMR)
AF:
AC:
860
AN:
23733
Ashkenazi Jewish (ASJ)
AF:
AC:
718
AN:
10911
East Asian (EAS)
AF:
AC:
1459
AN:
17068
South Asian (SAS)
AF:
AC:
675
AN:
26443
European-Finnish (FIN)
AF:
AC:
2323
AN:
23731
Middle Eastern (MID)
AF:
AC:
122
AN:
1802
European-Non Finnish (NFE)
AF:
AC:
20724
AN:
326182
Other (OTH)
AF:
AC:
1440
AN:
21321
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.311
Heterozygous variant carriers
0
2071
4142
6213
8284
10355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0105 AC: 977AN: 93077Hom.: 5 Cov.: 19 AF XY: 0.00870 AC XY: 203AN XY: 23337 show subpopulations
GnomAD4 genome
AF:
AC:
977
AN:
93077
Hom.:
Cov.:
19
AF XY:
AC XY:
203
AN XY:
23337
show subpopulations
African (AFR)
AF:
AC:
85
AN:
25690
American (AMR)
AF:
AC:
50
AN:
8309
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
2321
East Asian (EAS)
AF:
AC:
1
AN:
2949
South Asian (SAS)
AF:
AC:
1
AN:
2040
European-Finnish (FIN)
AF:
AC:
105
AN:
3479
Middle Eastern (MID)
AF:
AC:
3
AN:
180
European-Non Finnish (NFE)
AF:
AC:
696
AN:
46299
Other (OTH)
AF:
AC:
11
AN:
1217
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.